A single dose of Pegfilgrastim versus daily Filgrastim to evaluate the mobilization and the engraftment of autologous peripheral hematopoietic progenitors in malignant lymphoma patients candidate for high-dose chemotherapy
Authors:
- 1 December 2010
- journal article
- research article
- Published by Elsevier in Transfusion and Apheresis Science
- Vol. 43 (3) , 321-326
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- The role of pegfilgrastim in mobilization of hematopoietic stem cellsTransfusion and Apheresis Science, 2008
- A phase 2 pilot study of pegfilgrastim and filgrastim for mobilizing peripheral blood progenitor cells in patients with non-Hodgkin's lymphoma receiving chemotherapyHaematologica, 2008
- Efficacy of single dose pegfilgrastim in enhancing the mobilization of CD34+ peripheral blood stem cells in aggressive lymphoma patients treated with cisplatin-aracytin-containing regimensBone Marrow Transplantation, 2006
- Pharmacokinetics of PegfilgrastimPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2003
- Randomized, Multicenter, Open-Label Study of Pegfilgrastim Compared With Daily Filgrastim After Chemotherapy for LymphomaJournal of Clinical Oncology, 2003
- PegfilgrastimDrugs, 2002
- Autologous Transplantation for Diffuse Aggressive Non-Hodgkin’s Lymphoma in Patients Never Achieving Remission: A Report from the Autologous Blood and Marrow Transplant RegistryJournal of Clinical Oncology, 2001
- 2000 Update of Recommendations for the Use of Hematopoietic Colony-Stimulating Factors: Evidence-Based, Clinical Practice GuidelinesJournal of Clinical Oncology, 2000
- The ISHAGE Guidelines for CD34+ Cell Determination by Flow CytometryJournal of Hematotherapy, 1996
- Autologous Bone Marrow Transplantation as Compared with Salvage Chemotherapy in Relapses of Chemotherapy-Sensitive Non-Hodgkin's LymphomaNew England Journal of Medicine, 1995